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Introduction
Well-timed administration of disease-modifying therapy
is a keystone of contemporary treatment for patients
with JIA.
Objectives
The objective is to analyze the effect of medication therapy
carried out for patients in the first year of the disease and
timeframe for disease-modifying therapy administration.
Methods
23 adult patients of orthopedic surgery department who
underwent joint replacement in 2010–2013. Based on
patients survey and medical documents, we analyzed the
age of the disease onset, arthritis type, mode of therapy
taken in the first year of the disease, duration of the
disease by the time of disease-modifying therapy admin-
istration and social status during the study (education,
job, marital status, age and disease duration by the time
of the joint replacement).
Results
87% of the patients examined were women. Mean age of
the disease onset is 4.6 years (2–15 years). Polyarticular
type was found in 13 patients (56%), systemic and oligoar-
ticular types were observed in 22% each. In the first year
of the disease 4 patients were treated with glucocorticoids
(GC) (intra-articular and systemic injection); non-steroid
anti-inflammatory drugs (NSAID) were administered in
8 patients; 8 patients received combined therapy with
these drugs and one woman received disease-modifying
therapy in addition to the combination of these drugs.
Average duration of the disease by the time of disease-
modifying therapy administration was 6.5 years. In fact,
3 patients received methotrexate starting from the disease
onset, two patients were treated only in hospital condi-
tions. All patients finished school, 8 patients have been
educated at home: a girl since the second form and others
in senior school. 6 patients had vocational secondary
education, 7 patients had a higher education, 7 patients
were employed, 3 patients went on to further study,
5 patients had a family 3 of which were mothers. Mean
age of the patients by the time of the first joint replace-
ment was 23 years (17–35 years) and average disease dura-
tion was 15.9 years. One joint was replaced in 70% of
patients, two joints in 20% and three joints in 10%. 60% of
patients underwent hip replacement and 40% underwent
knee replacement.
Conclusion
This treatment was inadequate in the majority of
patients, though the condition of some patients was rela-
tively satisfactory for a long period that allowed them to
attend school. In 60% of patients with early onset of the
disease, 47 % had impairment in adolescent period.In one
woman elbow replacement was associated with an error
in rehabilitation treatment in childhood: redressment
after short duration of the disease led to fast ankylosing.
Severe functional disorders and low social activity were
caused by inadequate therapy administered at the early
stage of the disease. Nowadays, almost all patients with
chronic arthritis receive disease-modifying therapy in the
first 3–6 months, which inspires hope for better func-
tional and social results of their treatment in adult life.
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